McCarthy Christopher bought IDXG
August 20, 2026 · Form 4 insider transaction
McCarthy Christopher bought 277,009 shares of Interpace Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
277,009
Price
$0.00
Total value
N/A
InsiderMcCarthy Christopher
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after277,009
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date.